Critically ill patients benefit from early mobilization as it has been associated with increased muscle strength, shorter duration of mechanical ventilation, and reduced length of stay.
The Guardian Patient Management System has been validated in clinical studies to improve clinical outcomes.
In a landmark randomized clinical trial,
Guardian demonstrated:
In an initial feasibility study
Guardian demonstrated:
Real-world experience suggests a greater length of stay reduction for patients treated with the Guardian System.
By promoting perfusion, the Guardian System supports early and sustained mobility – key factors shown to accelerate ventilator weaning, shorten length of stay, and improve functional outcomes in hospitalized patients.2,3
Learn more about our 399-patient randomized controlled trial investigating adverse event prevention in high-risk acute care patients.
And see how Guardian played a key role in optimizing protection and management of critically ill, mechanically ventilated COVID-19 patients.
In addition to prevention, Guardian has also demonstrated significant improvement in healing trajectory for existing pressure injuries.
Please do not include any personal information in your message to us.
